Last update 08 May 2025

SHR-3167

Overview

Basic Info

Drug Type
Biological products
Synonyms
Target-
Action-
Mechanism-
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Jiangsu Hengrui Pharmaceuticals Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Active Organization
Jiangsu Hengrui Pharmaceuticals Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with SHR-3167
CTR20244274
/ RecruitingPhase 2
在二甲双胍单药或联合SGLT2抑制剂治疗血糖控制不佳 的2型糖尿病患者中，评估SHR-3167和甘精胰岛素的有效性和安全性的随机、开放、达标治疗、平行对照的II期临床研究
[Translation] A randomized, open-label, treat-to-target, parallel-controlled Phase II clinical study to evaluate the efficacy and safety of SHR-3167 and insulin glargine in patients with type 2 diabetes who have poor glycemic control on metformin alone or in combination with SGLT2 inhibitors
NCT06688123
/ RecruitingPhase 2
A Randomized, Open-label, Treat-to-target, Parallel-controlled, Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-3167 and Insulin Glargine in Patients With Type 2 Diabetes Mellitus With Metformin Alone or in Combination With SGLT2 Inhibitors
CTR20232412
/ RecruitingPhase 1
健康受试者和2型糖尿病患者单次皮下注射SHR-3167注射液的安全性、耐受性、药代动力学和药效学研究的I期临床试验
[Translation] A Phase I Clinical Trial to Study the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Subcutaneous Injection of SHR-3167 Injection in Healthy Subjects and Patients with Type 2 Diabetes
100 Clinical Results associated with SHR-3167
Login to view more data
100 Translational Medicine associated with SHR-3167
Login to view more data
100 Patents (Medical) associated with SHR-3167
Login to view more data
100 Deals associated with SHR-3167
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 2
China
Jiangsu Hengrui Pharmaceuticals Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd.
08 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free